ABSTRACT
Microbes are commonly sensitive to shifts in the physiological and pathological state of their hosts, including mothers and babies. From this perspective, the microbiome may be a good indicator for diseases during pregnancy and has the potential to be used for perinatal health monitoring. This is embodied in the application of microbiome from multi body sites for auxiliary diagnosis, early prediction, prolonged monitoring, and retrospective diagnosis of pregnancy and infant complications, as well as nutrition management and health products developments of mothers and babies. Here we summarized the progress in these areas and explained that the microbiome of different body sites is sensitive to different diseases and their microbial biomarkers may overlap between each other, thus we need to make a diagnosis prudently for those diseases. Based on the microbiome variances and additional anthropometric and physical data, individualized responses of mothers and neonates to meals and probiotics/prebiotics were predictable, which is of importance for precise nutrition and probiotics/prebiotics managements and developments. Although a great deal of encouraging performance was manifested in previous studies, the efficacy could be further improved by combining multi-aspect data such as multi-omics and time series analysis in the future. This review reconceptualizes maternal and infant health from a microbiome perspective, and the knowledge in it may inspire the development of new options for the prevention and treatment of adverse pregnancy outcomes and bring a leap forward in perinatal health care.
Subject(s)
Female , Humans , Infant, Newborn , Pregnancy , Microbiota , Probiotics/adverse effects , Retrospective StudiesABSTRACT
@#In recent years, cases of illegal addition of chemical substances into the TCMs and health-care products happened regularly. Therefore, it is particularly important to develop fast, sensitive and accurate analysis methods for detection of the adulterated chemical substances. Through literature survey of relevant papers published in 2016-2017, this article summarizes the application of various analytical techniques for adulterated chemical substances to the TCMs and health-care products with useful information for the further development of new methods and technologies in this field.
ABSTRACT
Gastrodia elata is a kind of precious Chinese materia medica, which showed good effect in the treatment of headache, improve learning and memory, antidepressant, and other neuropharmacology effects. In this paper, the neuropharmacology effects and corresponding chemical constituents of G. elata in the last ten years were summarized and sorted by referring the literature of CNKI and PubMed, as well as inquired the development of G. elata related drugs and health care products in the official website of the Chinese Food and Drug Administration, which provides reference to develop nervous and mental diseases products of G. elata.
ABSTRACT
The current situation and the latest progress of related health care functions, chemical composition, patents, and health care products of pine needle were systematically reviewed through searching and querying the State Food and Drug Administration website (SFDA), the Korean food safety net, the World Intellectual Property Database, and the State Intellectual Property Office of the People’s Republic of China. The development of health food products of pine needles can be based on its existing health care functions, health-care dosage forms, and its market and resources to further develop and expand the development of pine needles health care products and extend to the international market.
ABSTRACT
Objective:To investigate the consumption situation and cognition of health care products in hospitalized patients, ana-lyze the problems in purchasing and use of health care products to provide evidence for the correct selection and rational use of health care products. Methods:The investigation and analysis was conducted with an anonymous questionnaire on awareness and consumption situation of health care products in hospitalized patients. Results:The survey received 129 valid questionnaires, and more than 1/3 re-spondents did not know the differences between health care products and medicines, and 27. 91％ of them treated diseases with health care products, 57. 36％ of them purchased health care products per month, and 96. 12％ of them thought the efficacy of health care products were inconsistent with the advertising efficacy. Conclusion:Patients cannot distinguish health care products from medicines, and lack of trust in the health care products market. Corresponding measures should be performed to help patients purchase and use of health care products and safeguard their legitimate rights and interests.